World Obesity Day is an annual observance that highlights the global obesity epidemic. It’s also about raising awareness about causes, impacts, and solutions. This year’s World Obesity Day, observed on March 4, comes at a time of … Read more
If you’re on a GLP-1 weight loss journey, you may have experienced the frustration of feeling stuck in your progress, no matter how hard you’ve been working. This is commonly referred to as hitting a weight loss … Read more
GLP-1 medications like semaglutide (Ozempic® and Wegovy®) and tirzepatide (Zepbound® and Mounjaro®) have become go-to treatments for individuals managing type 2 diabetes and those working towards weight loss. These medications work by regulating blood sugar levels and … Read more
January may be the perfect time to start thinking about new health goals but achieving them doesn’t require drastic changes or complex routines. In fact, the best way to create lasting success is by simplifying your approach … Read more
While the holiday season can be a time for celebration and connection, it can also be filled with obligations, expectations, and stress. Ivím Health understands the importance of managing holiday stress while prioritizing your health and wellness … Read more
The holiday season often serves as a time to reflect on what truly matters: connection, joy, and well-being. Instead of viewing healthy habits as something reserved for the holidays, why not make them a part of your … Read more
Whether it’s the holiday season, a special celebration, or a regular week, meal planning while on GLP-1 therapy can be enjoyable and supportive of your wellness journey. If you’re taking GLP-1 medications like Ozempic®, Wegovy®, Zepbound®, Mounjaro®, … Read more
Understanding what to eat while taking Ozempic® (semaglutide), Wegovy® (semaglutide), or compounded semaglutide is crucial for maximizing weight loss benefits. This guide will provide a comprehensive list of foods to eat while on semaglutide and highlight the … Read more
FDA notice on Zepbound®/Mounjaro® shortage: On October 2, 2024, the U.S. Food and Drug Administration determined that the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, had ended. (Read more) Schedule a visit with an Ivim … Read more
FDA notice on Zepbound®/Mounjaro® shortage: On October 2, 2024, the U.S. Food and Drug Administration determined that the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, had ended. (Read more) Schedule a visit with an Ivim … Read more
